Page last updated: 2024-10-30

mesalamine and Dysgeusia

mesalamine has been researched along with Dysgeusia in 1 studies

Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.

Dysgeusia: A condition characterized by alterations of the sense of taste which may range from mild to severe, including gross distortions of taste quality.

Research Excerpts

ExcerptRelevanceReference
"The prednisolone dose was reduced to 7."1.51Case report of patient with a Cronkhite-Canada syndrome: sustained remission after treatment with corticosteroids and mesalazine. ( Drebber, U; Kaufmann, T; Kütting, F; Mertens, J; Nierhoff, D; Schulte, S; Steffen, HM; Töx, U, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schulte, S1
Kütting, F1
Mertens, J1
Kaufmann, T1
Drebber, U1
Nierhoff, D1
Töx, U1
Steffen, HM1

Other Studies

1 other study available for mesalamine and Dysgeusia

ArticleYear
Case report of patient with a Cronkhite-Canada syndrome: sustained remission after treatment with corticosteroids and mesalazine.
    BMC gastroenterology, 2019, Feb-27, Volume: 19, Issue:1

    Topics: Aged; Alopecia; Anti-Inflammatory Agents, Non-Steroidal; Diagnosis, Differential; Diarrhea; Drug Adm

2019